Nhận xét về một số biến chứng cấp liên quan đến các chế phẩm máu được dùng để thay máu trong điều trị vàng da tăng Bilirubin ở trẻ sơ sinh

Objective: Some remark on safety of blood products, which used for exchange transfusion in neonatal severity of jaundice through 26 cases were carried out from may 2009 to april 2012 at the Viet Nam - Cuba Dong Hoi friendship hospital. Methods: ã Retrospective Cross-Sectional Survey. ã Using WHO Guidelines for recognition of acute transfusion reactions. Results and conclusions: During and after exchange transfusion: - General risks are the same as with any transfusion: Acute transfusion reactions (0.0 percent). ã - Other possible complications include: Anaemia/Polycythaemia (0.0 percent), Thrombocytopenia (23.08 percent), Infection (0.0 percent). - Changes in blood chemistry: Hypoglycaemia (0.0 percent), Hypocalcaemia (0.0 percent), Hypernatraemia (11.54 percent), Hyperkalaemia (0.0 percent), Mild coagulopathy without clinical (7.69 percent).